🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Longterm Influence of Pediatric Long COVID Syndrome

Recruitingn/aAges 6 Years - 18 YearsAllNational Taiwan University Hospital
NCT05566392 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

We enroll pediatric patients who were diagnosed COVID-19 for main observation target. We will perform brain MRI and neuropsychiatric evaluation 4-6 months after COVID-19 diagnosed. We also enroll healthy age- and gender-matched participant for cross-over comparison. We will perform same evaluation process one year later for longitudinal evaluation

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 6-18 years old * Has been diagnosed COVID-19 before Exclusion Criteria: * History of neuropsychiatric disorders * Have some device not allowed for MRI
💊

What it tests

  • Brain MRI
📍

Where

1 site
National Taiwan University Children Hospital Pediatric Neurology Department
Taipei, Taiwan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy